173 related articles for article (PubMed ID: 21892049)
1. Sarcomatoid hepatocellular carcinoma diagnosed by FDG PET/CT.
Mi B; Wan W; Yu C; You X; Xu Q
Clin Nucl Med; 2011 Oct; 36(10):925-7. PubMed ID: 21892049
[No Abstract] [Full Text] [Related]
2. A hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma detected by F-18 FDG PET/CT imaging.
Pan JH; Dong MJ; Ouyang XB
Clin Nucl Med; 2011 Dec; 36(12):1137-9. PubMed ID: 22064094
[No Abstract] [Full Text] [Related]
3. Bilateral breast uptake demonstrated on FDG PET/CT scans in 3 male patients with hepatocellular carcinomas.
Wu YC; Hsieh TC; Sun SS; Yen KY; Kao CH
Clin Nucl Med; 2012 May; 37(5):520-1. PubMed ID: 22475911
[TBL] [Abstract][Full Text] [Related]
4. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB
J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
[TBL] [Abstract][Full Text] [Related]
6. Hepatocelluar carcinoma in an accessory lobe of the liver revealed by 11C-acetate PET with a negative finding on FDG imaging.
Huo L; Dang Y; Feng R; Zhuang H; Li F
Clin Nucl Med; 2012 Apr; 37(4):393-5. PubMed ID: 22391716
[No Abstract] [Full Text] [Related]
7. (18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma.
Lee SD; Kim SH; Kim YK; Kim C; Kim SK; Han SS; Park SJ
Transpl Int; 2013 Jan; 26(1):50-60. PubMed ID: 23106431
[TBL] [Abstract][Full Text] [Related]
8. Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma.
Pant V; Sen IB; Soin AS
Nucl Med Commun; 2013 Aug; 34(8):749-57. PubMed ID: 23689586
[TBL] [Abstract][Full Text] [Related]
9. A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection.
Fartoux L; Balogova S; Nataf V; Kerrou K; Huchet V; Rosmorduc O; Talbot JN
Nucl Med Commun; 2012 Jul; 33(7):757-65. PubMed ID: 22504293
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic effect of transcatheter arterial thromboembolization of hepatocellular carcinoma as for residual viable tumors related to lipoidal density areas and detected by (18)F-FDG PET/CT and CT.
Li J; Shao W; Song J; Shi C; Chen H; Cong N
Hell J Nucl Med; 2013; 16(1):64-5. PubMed ID: 23789119
[No Abstract] [Full Text] [Related]
11. [18F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma.
Asman Y; Evenson AR; Even-Sapir E; Shibolet O
Liver Transpl; 2015 May; 21(5):572-80. PubMed ID: 25644857
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT of Primary Mediastinal Hepatoid Adenocarcinoma.
Hu N; Tan Y; Luo J; Cheng Z; Wang Y
Clin Nucl Med; 2016 Apr; 41(4):321-2. PubMed ID: 26914554
[TBL] [Abstract][Full Text] [Related]
13. F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma.
Wu HB; Wang QS; Li BY; Li HS; Zhou WL; Wang QY
Clin Nucl Med; 2011 Dec; 36(12):1092-7. PubMed ID: 22064078
[TBL] [Abstract][Full Text] [Related]
14. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
[TBL] [Abstract][Full Text] [Related]
15. Solitary splenic metastasis from hepatocellular carcinoma detected on (18)F-FDG PET/CT.
Kim DH; Jeong SY; Lee SW; Lee J; Ahn BC
Clin Nucl Med; 2015 Jun; 40(6):e325-7. PubMed ID: 25546205
[TBL] [Abstract][Full Text] [Related]
16. Castleman disease of the porta hepatis mimicking exophytic hepatocellular carcinoma on CT, MRI, and FDG PET/CT.
Dong A; Dong H; Zuo C
Clin Nucl Med; 2014 Jan; 39(1):e69-72. PubMed ID: 23486333
[TBL] [Abstract][Full Text] [Related]
17. A Case of Oral Metastasis From Hepatocellular Carcinoma Displayed on 18F-FDG PET/CT Imaging.
Jiang L; Gu T; Liu F; Luan L; Shi H
Clin Nucl Med; 2016 Jan; 41(1):72-3. PubMed ID: 26359556
[TBL] [Abstract][Full Text] [Related]
18. FDG PET/CT and enhanced CT imaging of tumor heterogeneity in hepatocellular carcinoma: imaging-pathologic correlation.
Dong A; Yu H; Wang Y; Dong H; Zuo C
Clin Nucl Med; 2014 Sep; 39(9):808-10. PubMed ID: 24092231
[TBL] [Abstract][Full Text] [Related]
19. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC
Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351
[TBL] [Abstract][Full Text] [Related]
20. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]